Author

Ratul Mukerji

Nurix (United States)ORCID 0000-0002-6835-3182Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Frederick CoheniD· 3 shared Arthur Sands· 2 shared Austin Tenn-McClellaniD· 2 shared Brandon J. Bravo· 2 shared Dahlia R. WeissiD· 2 shared Dhwani HariaiD· 2 shared Gwenn M. HanseniD· 2 shared Ryan B. RountreeiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Frederick CohenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Bexobrutideg: A Selective, Catalytic Degrader of Bruton's Tyrosine Kinase Overcomes Inhibitor Resistance and Suppresses Autoantibody-Mediated Disease

Mark Noviski, P Auger, Danielle Bautista, Nivetha Brathaban, Brandon J. Bravo, Robert Cass, Ganesh Cherala, Thomas C. Fung, Stefan Gajewski, Dhwani Haria, Zewen Jiang, Dane E. Karr, Aileen Kelly, Daisuke Kato, Zef A. Könst, , Frederick Cohen

Bexobrutideg is a BTK degrader that overcomes inhibitor resistance and suppresses autoimmune disease by catalytically degrading BTK.

bioRxiv · Aug 4, 2026 · PreprintCancer Biology

Small-molecule CBLB inhibitor abolishes EGFR ubiquitination, reduces receptor endocytosis and diminishes cell motility signaling

Itziar Pinilla‐Macua, Ratul Mukerji, Frederick Cohen, Alexander D. Sorkin

The paper uses a CBLB inhibitor to show that EGFR ubiquitination is essential for clathrin-mediated endocytosis and cell motility, but not for other downstream signaling pathways.

Proceedings of the National Academy of Sciences · Mar 27, 2026Peer-reviewedCell Biology

Discovery and characterization of small molecule inhibitors of CBL-B that act as intramolecular glue to enhance T-cell anti-tumor activity

Stefan Gajewski, Asad M. Taherbhoy, Kathleen Boyle, Jennifa Gosling, Jilliane Perkins, Ketki Dhamnaskar, Julie Sheung, Kenton Baker, Nichole O'Connell, Brandon J. Bravo, Ratul Mukerji, Austin Tenn-McClellan, Katherine Kurylo, Dhwani Haria, Marilena Gallotta, , Frederick Cohen

bioRxiv · Jan 24, 2026 · PreprintImmunology